[Clobetasol vs. testosterone in the treatment of lichen sclerosus of the vulvar region].
The paper describes a study carried out in 40 patients affected by lichen sclerosus (LS) of the vulva. The mean age of patients was 60.9 years (range 27-83) and 31 were in menopause. Patients were divided randomly into two groups of 20. The symptoms (itching, burning, pain, dyspareunia), clinical aspects (atrophy, hyperkeratosis, sclerosis) and histological alterations (atrophy of the epithelium, edema, inflammatory infiltrate, fibrosis) were quantified in each patient by a score. The mean scores relating to the three parameters examined were then calculated for each group. One group was treated with testosterone propionate 2% and the other with a strong synthetic corticosteroid, clobetasol dipropionate 0.05%. After 24 weeks of treatment patients were again evaluated in relation to clinical (symptoms and clinical aspects) and histological parameters, following the procedure used before the start of treatment. The mean scores obtained were then compared with those before the start of treatment. Statistical analyses were performed using Student's t-test. Testosterone was found to be effective in relation to symptoms but no significant change was observed in relation to clinical aspects and histological alterations. It also caused major secondary effects which led to the suspension of treatment in one patient. Clobetasol was shown to be highly effective both in relation to symptoms and in terms of clinical aspects and histological alterations, and did not cause any noteworthy collateral effects, especially contact dermatitis. In the context of the objective parameters examined in this study, sclerosis and hyperkeratosis were easily modified by corticosteroid treatment in comparison to atrophy, especially in those patients with a longer duration of disease.(ABSTRACT TRUNCATED AT 250 WORDS)
Cattaneo
A
A
Istituto di Ginecologia e Ostetricia, Università degli Studi di Firenze.
De Marco
A
A
Sonni
L
L
Bracco
G L
GL
Carli
P
P
Taddei
G L
GL
D000368:Aged; D002990:Clobetasol / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008010:Lichen Planus / Q000188:drug therapy*; D008875:Middle Aged; D012598:Sclerosis / Q000188:drug therapy; D013739:Testosterone / Q000627:therapeutic use*; D014845:Vulvar Diseases / Q000188:drug therapy / Q000382:microbiology*
D013739:Testosterone; D002990:Clobetasol
Clobetasolo vs testosterone nel trattamento del lichen scleroso della regione vulvare.